Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic combination product containing butalbital, aspirin, and caffeine from Westminster Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Aspirin, and Caffeine (butalbital, aspirin, and caffeine)

Snippet

SUPPL AP for BUTALBITAL, ASPIRIN, AND CAFFEINE (BUTALBITAL, ASPIRIN, AND CAFFEINE)